US EditionPublished • loading... • Updated
Decarbonation: Meribel Pharma Solutions Invests 1.2 Million Euros in Gironde to Benefit From Renewable Heat
Summary by usinenouvelle.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Meribel Pharma Solutions, a European CDMO specialised in tailor-made pharmaceutical solutions, has taken a major step in its energy transition strategy with the introduction of a new low-carbon infrastructure at its site in Pessac (Gironde). Thanks to an investment of €1.2 million, of which just over €400,000 in grants granted by Ademe via the Fonds Chaleur and Décarb-Flash devices, the pharmaceutical site has been equipped with a new facility, …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
